ClinicalTrials.gg
Not yet recruitingNCT07081321Updated Sep 10, 2026

The Effect of Different Delivery Positions on Pelvic Floor Function.

An interventional study of Lithotomy position and Lateral Position in Stress Urinary Incontinence (SUI), sponsored by Peking University People's Hospital. Not yet recruiting at 1 site in China. Open to female participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-10.

Sponsored by Peking University People's Hospital · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
1,992
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 22 studies in Urinary Incontinence, Stress with a site in China — 6 open to participants now, 6 under way, 1 of them phase 3. Urinary Incontinence, Stress · China.

Planned enrollment
Largest of 20
1,992 · median 137
Started
2026
with 2 others
No phase
15 of 22
3 open now
Registered
18th of 22
by date
Lead sponsor
1 of 22
Peking University People's Hospital

Among the 22 studies in Urinary Incontinence, Stress with a site in China, this one has the largest planned enrollment of the 20 interventional ones that give a count, is one of 3 that started in 2026, is one of 15 with no phase, and was the 18th registered.

Urinary Incontinence, Stress

653 studies on the registry are indexed under Urinary Incontinence, Stress; 121 are open to participants now.

Browse Urinary Incontinence, Stress studies →

Open to participants now

6 of the 22 studies in Urinary Incontinence, Stress with a site in China are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 74 Urinary Incontinence, Stress studies recruiting now, 42 (57%) set no upper age limit and 18 (24%) stop at 75 or younger; 2 take children under 18; 16 take healthy volunteers.

This study: 20 Years to 40 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 22 studies in Urinary Incontinence, Stress with a site in China, or all of them as a file.
02

Study summary

This study is a prospective, multicenter, randomized controlled trial. Baseline data will be collected from eligible subjects recruited during the third trimester of pregnancy. Participants will be randomized into three groups when cervical dilation reaches 2 cm based on delivery position: lithotomy position, upright position, and lateral position. During the second stage of labor, data regarding delivery positions, duration of each position, and other obstetric conditions will be recorded. Pelvic floor function assessments will be performed in the postpartum period to evaluate the outcomes.

03

Conditions studied

  • Stress Urinary Incontinence (SUI)

Keywords

  • Stress Urinary inconticence
  • Dlivery position
  • pevic floor muscle
04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Aged 20 to 40 years.
  2. Singleton, cephalic presentation, full-term primipara.
  3. Absence of cephalopelvic disproportion.
  4. Estimated fetal weight (EFW) \< 4000 g.
  5. Intended vaginal delivery and scheduled for postpartum follow-up at our hospital.
  6. Voluntary participation with provision of .

Exclusion criteria

Exclusion Criteria:

  1. Moderate or severe stress urinary incontinence prior to pregnancy.
  2. Pelvic Organ Prolapse Quantification (POP-Q) stage ≥ III, or a history of treatment for pelvic floor dysfunction.
  3. Uncontrolled systemic medical diseases, or a history of asthma, allergic rhinitis, and constipation prior to pregnancy.
  4. Presence of to vaginal delivery.
  5. Presence of contraindications to the Valsalva maneuver (e.g., severe cardiopulmonary diseases, cervical incompetence, etc.).

Withdrawal Criteria:

  1. The patient's clinical condition becomes unsuitable for continued study participation and follow-up.
  2. The subject requests to withdraw from the study.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
1,992 participants (estimated)

Study arms

  • Experimental
    Lithotomy Position Group

    Participants in the lithotomy position group were in the lithotomy position at the second stage of labor of delivery

    Behavioral: Lithotomy position

  • Experimental
    Upright Position Group

    Participants in the upright position group were in the upright position at the second stage of labor of delivery.

    Behavioral: Upright Position

  • Experimental
    Lateral Position.

    Participants in the lateral position group were in the lateral position at the second stage of labor of delivery.

    Behavioral: Lateral Position

Interventions

  • BehavioralLithotomy position

    Participants in the lithotomy decubitus position group were in the lithotomy position at the second stage of labor of delivery.

  • BehavioralLateral Position

    Participants in the lateral position group were in the lateral position at the second stage of labor of delivery.

  • BehavioralUpright Position

    Participants in the upright position group were in the upright position at the second stage of labor of delivery.

06

What researchers measure

Primary outcomes

  1. Stress urinary incontence (SUI) occurrence at 6 weeks postpartum

    Time frame: at 6 (±2) weeks postpartum

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided — Protection of research process and results For unpublished research, data sharing may lead to the results being published first, damaging the academic rights and interests of the research team.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Dec 2027, 15 months later.

Of 226 non-industry interventional studies with no phase under Urinary Incontinence, Stress, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 15 months is below that.

Counting every sponsor, half of 267 studies reached it within 19 months; a quarter within 9 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 26, 2025
First posted
Jul 23, 2025
StartEst.
Sep 20, 2026
Primary completionEst.
Dec 31, 2027
CompletionEst.
Dec 31, 2028
Last update
Sep 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07081321
Collaborators
Luohe Central Hospital, The Third Xiangya Hospital of Central South University, Zhengzhou Central Hospital, Jincheng People's Hospital, Tongzhou Maternal and Child Healthcare Hospital of Beijing, Hangzhou maternity and child health care hospital
Responsible party
Gao lei (Attending Physician, Peking University People's Hospital) — Principal investigator
First posted
Jul 23, 2025
Start date
Sep 20, 2026 (estimated)
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Sep 10, 2026

Study contacts

Lei Gao, MD
Contact
1694833009@qq.com
+8617669675336

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion